Company: CHPG
Filing Date: 2025-11-17
Form Type: 10-Q
Source: 0001213900-25-111468
Chunk: 68

Company: ChampionsGate Acquisition Corp
Filing Date: 2025-11-17
Form: 10-Q
Item: Part I, Item 8
Chunk 68
---
able  
    Non-Redeemable 

    Class A  
    Class A and  Class B  
    Class A  
    Class A and  Class B 

    Ordinary  
    Ordinary  
    Ordinary  
    Ordinary 

    Shares  
    Shares  
    Shares  
    Shares 
  
    Basic and diluted net income (loss) per ordinary share: 

    Numerators: 

    Allocation of net income (loss) 
    $302,249  
    $192,656  
    $          -  
    $(172,120)
  
    Denominators: 

    Basic and diluted weighted average shares outstanding 
     3,407,721  
     2,172,110  
     -  
     1,887,097​(1)(2)
  
    Basic and diluted net income (loss) per ordinary share 
    $0.09  
    $0.09  
    $-  
    $(0.09)

  (1) Excludes up to 283,064 of the Class B ordinary shares that were subject
to surrender by the Sponsor for no consideration depending on the extent to which the underwriters’ over-allotment is exercised
(see Note 5). On May 29, 2025, the Company consummated the IPO of 7,475,000 units at $10.00 per unit, which includes the full exercise
of the underwriter’s over-allotment option, therefore the 283,064 Class B ordinary shares are no longer subject to forfeiture. 

  (2) Gives retroactive effect to forfeiture of 4,507,258 shares issue to the Sponsor at par value on April 30, 2025.  

9

Fair Value of Financial Instruments

The fair value of the Company’s assets and
liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures” (“ASC
820”), approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

The Company applies ASC 820, which establishes
a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an
exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or
most advantageous market in an orderly